Ignite Creation Date:
2025-12-24 @ 4:55 PM
Ignite Modification Date:
2026-02-23 @ 12:23 PM
Study NCT ID:
NCT02124850
Status:
TERMINATED
Last Update Posted:
2019-10-25
First Post:
2014-04-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase Ib Study of Neoadjuvant of Cetuximab Plus Motolimod and Cetuximab Plus Motolimod Plus Nivolumab
Sponsor:
Celgene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-10-28
Start Date Type:
ACTUAL
Primary Completion Date:
2016-08-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-10-31
Completion Date Type:
ACTUAL
First Submit Date:
2014-04-22
First Submit QC Date:
None
Study First Post Date:
2014-04-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-10-23
Last Update Post Date:
2019-10-25
Last Update Post Date Type:
ACTUAL